Zepbound is indicated for adults with obesity (with a BMI of 30 kg/m2 or greater), or those who are overweight (with a BMI of 27 kg/m2 or greater) and also have weight-related medical problems such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease, to lose weight and keep it off
DiBaise, M
Khajuria DK, Vasireddi R, Trebbin M, Karasik D, Razdan R (2017) Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: in vitro and pharmacodynamic evaluation
Mejora de la calidad del sueo: Contribuye a dormir mejor al reducir los niveles de estrs y promover el descanso
this may helptreat and address several weight-related conditions, including heart conditions, diabetes and musculoskeletal issues